Published in Front Neurol on May 25, 2012
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58
Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (2007) 8.68
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke (1993) 6.94
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol (1998) 5.93
Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol (2010) 5.79
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2008) 5.77
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 5.68
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol (2008) 5.40
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology (2006) 4.88
Cerebral amyloid angiopathy. A critical review. Stroke (1987) 4.56
Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke (1997) 4.55
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol (1999) 3.67
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol (1995) 3.60
CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke (2007) 3.43
Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology (2007) 3.38
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med (2000) 3.23
Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology (2004) 3.21
Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke (2004) 3.07
Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol (2012) 2.94
Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke (2004) 2.92
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain (2007) 2.88
Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke (1984) 2.86
Long-term mortality after intracerebral hemorrhage. Neurology (2006) 2.71
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol (2007) 2.69
Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology (2011) 2.67
Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology (2006) 2.38
Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol (1971) 2.35
The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology (2007) 2.13
Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc Natl Acad Sci U S A (2003) 2.13
Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke (1999) 2.12
Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol (2007) 2.02
Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke (1996) 2.00
High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1997) 2.00
Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke (1999) 1.94
An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab (1998) 1.94
The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke (2009) 1.89
Microbleeds versus macrobleeds: evidence for distinct entities. Stroke (2009) 1.83
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 1.74
Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg (2002) 1.72
Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke (2004) 1.70
Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol (2008) 1.63
Cerebral microhemorrhage. Stroke (2006) 1.58
Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients. Stroke (2009) 1.58
Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke (1998) 1.58
Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology (1998) 1.56
Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med (2006) 1.55
Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol (1996) 1.54
Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol (1986) 1.50
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke (2003) 1.50
Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke (1997) 1.48
Theoretic basis and technical implementations of CT perfusion in acute ischemic stroke, part 1: Theoretic basis. AJNR Am J Neuroradiol (2009) 1.46
Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology (2009) 1.43
11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology (2010) 1.43
Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke (2004) 1.41
Theoretic basis and technical implementations of CT perfusion in acute ischemic stroke, part 2: technical implementations. AJNR Am J Neuroradiol (2009) 1.32
Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication. Arch Neurol (2008) 1.31
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol (1999) 1.31
Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke (1984) 1.30
The spot sign in intracerebral hemorrhage: the importance of looking for contrast extravasation. Cerebrovasc Dis (2009) 1.30
F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain. J Med Chem (2005) 1.30
Defining the CT angiography 'spot sign' in primary intracerebral hemorrhage. Can J Neurol Sci (2009) 1.28
Vascular and nonvascular mimics of the CT angiography "spot sign" in patients with secondary intracerebral hemorrhage. Stroke (2008) 1.27
APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology (2008) 1.24
Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke (2007) 1.23
Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke (1997) 1.22
MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol (1996) 1.20
Contrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases. Stroke (2011) 1.18
18F-labeled styrylpyridines as PET agents for amyloid plaque imaging. Nucl Med Biol (2006) 1.16
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke (2009) 1.16
Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol (2005) 1.12
The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2011) 1.10
Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke (2000) 1.05
The evolution of stroke in Quebec: a 15-year perspective. Neurology (2007) 1.03
Contrast extravasation predicts hematoma growth: where to now? AJNR Am J Neuroradiol (2008) 1.00
Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage. Crit Care Med (2001) 0.95
Early rate of contrast extravasation in patients with intracerebral hemorrhage. AJNR Am J Neuroradiol (2011) 0.94
Dynamic nature of the CT angiographic "spot sign". Br J Radiol (2010) 0.93
High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1996) 0.90
Ultrastructural features of cerebral amyloid angiopathy. Hum Pathol (1982) 0.89
Routine use of gradient-echo MRI to screen for cerebral amyloid angiopathy in elderly patients. AJR Am J Roentgenol (2004) 0.87
The spot sign is more common in the absence of multiple prior microbleeds. Stroke (2010) 0.83
Simultaneous bleeding from multiple lenticulostriate arteries in hypertensive intracerebral haemorrhage. Neuroradiology (1995) 0.82
Ultra-early hemostatic therapy for primary intracerebral hemorrhage: a review. Can J Neurol Sci (2005) 0.81
Extravasation of angiographic contrast material in hypertensive intracerebral hemorrhage. J Neurosurg (1972) 0.78
Importance of protein content in the edema fluid for the resolution of brain edema. Adv Neurol (1990) 0.78
Predictors of hematoma growth? Stroke (1998) 0.76
Extravasation of contrast medium during both computed tomography and cerebral angiography. Surg Neurol (1983) 0.76
Extravasation of contrast medium into blood clot in acute traumatic intraventricular hemorrhage. Neurol Med Chir (Tokyo) (1985) 0.76
CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke (2007) 3.43
Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol (2012) 2.94
Reperfusion is a stronger predictor of good clinical outcome than recanalization in ischemic stroke. Radiology (2013) 1.67
Primary central nervous system vasculitis in children. Arthritis Rheum (2006) 1.62
Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients. Stroke (2009) 1.58
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Systematic review, critical appraisal, and analysis of the quality of economic evaluations in stroke imaging. Stroke (2014) 1.39
Defining the CT angiography 'spot sign' in primary intracerebral hemorrhage. Can J Neurol Sci (2009) 1.28
Vascular and nonvascular mimics of the CT angiography "spot sign" in patients with secondary intracerebral hemorrhage. Stroke (2008) 1.27
Certainty of stroke diagnosis: incremental benefit with CT perfusion over noncontrast CT and CT angiography. Radiology (2010) 1.25
Radiation dose from multidetector row CT imaging for acute stroke. Neuroradiology (2009) 1.22
Case 178: Parry-Romberg syndrome. Radiology (2012) 1.21
Evolution of computed tomography angiography spot sign is consistent with a site of active hemorrhage in acute intracerebral hemorrhage. Stroke (2013) 1.18
Global hemispheric CT hypoperfusion may differentiate headache with associated neurological deficits and lymphocytosis from acute stroke. Stroke (2008) 1.15
Contrast-induced nephropathy and dehydration. Can Assoc Radiol J (2013) 1.08
White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study. Radiology (2008) 1.08
Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly. Neurology (2013) 1.08
Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage. Stroke (2009) 1.05
Intracranial arterial fenestrations: frequency on CT angiography and association with other vascular lesions. Surg Radiol Anat (2008) 1.04
Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease. Arthritis Rheum (2005) 1.02
Interobserver agreement of ASPECT score distribution for noncontrast CT, CT angiography, and CT perfusion in acute stroke. Stroke (2012) 1.01
Quantomo: validation of a computer-assisted methodology for the volumetric analysis of intracerebral haemorrhage. Int J Stroke (2011) 1.01
CT angiographic depiction of a supraclinoid ICA fenestration mimicking aneurysm, confirmed with catheter angiography. Surg Radiol Anat (2007) 0.95
The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial. Int J Stroke (2013) 0.93
Comparison of CTA to DSA in determining the etiology of spontaneous ICH. Can J Neurol Sci (2009) 0.93
Venous phase of computed tomography angiography increases spot sign detection, but intracerebral hemorrhage expansion is greater in spot signs detected in arterial phase. Stroke (2014) 0.92
Rare frontal lobe intraparenchymal epidermoid cyst with atypical imaging. J Clin Neurosci (2012) 0.91
Case of the month #171: osteogenesis imperfecta of the temporal bone. Can Assoc Radiol J (2011) 0.90
Characterization of carotid plaque hemorrhage: a CT angiography and MR intraplaque hemorrhage study. Stroke (2010) 0.88
The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. J Neuroinflammation (2011) 0.88
Automatic volumetry on MR brain images can support diagnostic decision making. BMC Med Imaging (2008) 0.87
Magnetic resonance imaging of facial nerve schwannoma. Laryngoscope (2009) 0.87
Comparison of computed tomography angiography with digital subtraction angiography in the assessment of clipped intracranial aneurysms. J Comput Assist Tomogr (2010) 0.86
Multicenter accuracy and interobserver agreement of spot sign identification in acute intracerebral hemorrhage. Stroke (2013) 0.86
Histopathological characteristics of the "spot sign" in spontaneous intracerebral hemorrhage. Arch Neurol (2012) 0.84
The spot sign is more common in the absence of multiple prior microbleeds. Stroke (2010) 0.83
Planimetric hematoma measurement in patients with intraventricular hemorrhage: is total volume a preferred target for reliable analysis? Stroke (2012) 0.82
Severe hypomagnesemia associated with reversible subacute ataxia and cerebellar hyperintensities on MRI. Neurologist (2012) 0.82
Low dose CT perfusion in acute ischemic stroke. Neuroradiology (2014) 0.82
Acute Multi-modal Neuroimaging in a Porcine Model of Endothelin-1-Induced Cerebral Ischemia: Defining the Acute Infarct Core. Transl Stroke Res (2015) 0.80
Traumatic stapes fracture with rotation and subluxation into the vestibule and pneumolabyrinth. Laryngoscope (2009) 0.80
CTA, MR, and MRA imaging of carotidynia: case report. Can J Neurol Sci (2009) 0.80
Spinal epidural hematoma following epidural catheter removal in a paraplegic patient. J Clin Anesth (2009) 0.80
The evolution of the cerebral blood volume abnormality in patients with ischemic stroke: a CT perfusion study. Acta Radiol (2012) 0.80
Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke (2006) 0.79
Perfusion CT for selecting patients with acute ischemic stroke for intravenous thrombolytic therapy. Radiology (2014) 0.79
Chondromyxoid fibroma of the mastoid facial nerve canal mimicking a facial nerve schwannoma. Laryngoscope (2009) 0.79
NASCET percent stenosis semi-automated versus manual measurement on CTA. Can J Neurol Sci (2012) 0.79
Spinal neurocysticercosis manifesting as recurrent aseptic meningitis. Can J Neurol Sci (2010) 0.76
Emergency Imaging of Intracerebral Haemorrhage. Front Neurol Neurosci (2015) 0.76
Reproducibility of semi-automated measurement of carotid stenosis on CTA. Can J Neurol Sci (2010) 0.76
Susac's Syndrome. Can J Neurol Sci (2011) 0.76
Bilateral Type II Persistent Proatlantal Intersegmental Arteries. Can J Neurol Sci (2013) 0.76
Contrast extravasation: a surrogate marker of primary intracerebral hemorrhage and secondary expansion. Arch Neurol (2012) 0.75
Falsely claiming use of NASCET percentage stenosis method. Radiology (2009) 0.75
Should modeling methodology suppress anatomic excellence? Stroke (2009) 0.75
Aspergillosis of the Petrous Apex and Meckel's Cave. Skull Base (2010) 0.75
Author response. Neurology (2013) 0.75
The CLOQS trial protocol: a cluster-randomized trial evaluating a simple, low-cost intervention to reduce treatment times in acute stroke. Int J Stroke (2013) 0.75
Multifocal cerebellar liponeurocytoma. Can J Neurol Sci (2013) 0.75
Diffusion Tensor Imaging Tractography of the Facial Nerve in Patients With Cerebellopontine Angle Tumors. Otol Neurotol (2016) 0.75
Diffuse ischemia in noncontrast computed tomography predicts outcome in patients in intensive care unit. Can Assoc Radiol J (2011) 0.75
Intrinsic arteriovenous malformation of the trigeminal nerve. Can J Neurol Sci (2010) 0.75
An Algorithm for Managing Intraosseous Vascular Anomalies of the Craniofacial Skeleton. J Craniofac Surg (2017) 0.75
CT-based Techniques for Brain Perfusion. Top Magn Reson Imaging (2017) 0.75
Thoracic myelopathy from coincident fluorosis and epidural lipomatosis. Can J Neurol Sci (2010) 0.75
Dipyridamole Treatment Prior to Stroke Onset: Examining Post-stroke Cerebral Circulation and Outcome in Rabbits. Transl Stroke Res (2011) 0.75
Case of the month #166: synovial chondromatosis of the temporal mandibular joint. Can Assoc Radiol J (2011) 0.75
Turning a stroke into a TIA: curative thrombolysis with combined intravenous and intra-arterial tPA. CJEM (2006) 0.75